KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Deferred Taxes: 2021

Historic Deferred Taxes for AbCellera Biologics (ABCL) over the last 1 years, with Dec 2021 value amounting to $1.2 million.

  • AbCellera Biologics' Deferred Taxes was N/A to $1.2 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$2.0 million, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2023, which is 192.72% up from last year.
  • Per AbCellera Biologics' latest filing, its Deferred Taxes stood at $1.2 million for Q4 2021, which was up 131.05% from -$4.0 million recorded in Q3 2021.
  • In the past 5 years, AbCellera Biologics' Deferred Taxes registered a high of $1.2 million during Q4 2021, and its lowest value of -$4.0 million during Q3 2021.
  • Moreover, its 1-year median value for Deferred Taxes was $378,000 (2021), whereas its average is -$504,500.